- IPC GENERAL
- IPC News
With great sadness, the International Psoriasis Council (IPC) shares that Craig L. Leonardi, MD, an IPC founding member and former IPC President, passed away in St. Louis, Missouri, on Oct. 8, 2026, after a long illness.
Dr. Leonardi was a leading clinical investigator whose work shaped how physicians treat psoriasis today. He served as principal investigator on more than 200 clinical trials during his 23 years at Central Dermatology, his practice in St. Louis. He authored more than 250 publications, including the pivotal phase 3 trials of etanercept and ustekinumab that helped usher in the biologic era in psoriasis.
As a founding member and former President, he helped build IPC into a global educational and academic organization in the field of psoriasis. Colleagues around the world knew him for his careful, honest reading of clinical evidence, his engaging lectures, and his dedication to teaching young dermatologists. Dr. Leonardi’s commitment to education lives on in Take Ten with IPC, the video series he envisioned. Launched in 2020, Take Ten offers clinicians brief, expert-led presentations they can watch in about 10 minutes. Today, more than 40 Take Ten videos are available in the IPC Resource Library, and the series continues to grow.
We extend our heartfelt condolences to Carmen, his wife of 45 years, to his family, and to all who learned from and worked alongside him. His family asks that those who wish to honor his memory donate to the National Psoriasis Foundation (NPF).
IPC has made a donation in Dr. Leonardi’s memory to recognize his lasting impact on the psoriasis community.
A full In Memoriam by IPC President Bruce Strober, MD, PhD, will be published soon in the Journal of the American Academy of Dermatology (JAAD).
























